FACULTAD DE CIENCIAS BIOMÉDICAS Y DE LA SALUD
Facultad
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (68)
2023
-
Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis
European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128
-
Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
Cancer Medicine, Vol. 12, Núm. 14, pp. 14892-14901
-
Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study
Neurologia, Vol. 38, Núm. 6, pp. 379-386
-
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study
Thrombosis Journal, Vol. 21, Núm. 1
-
Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction
Clinical Research in Cardiology
-
The current clinical practice for management of post-infarction ventricular septal rupture: a European survey
European Heart Journal Open, Vol. 3, Núm. 5
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)
Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30
-
XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (II)
Revista de neurologia, Vol. 77, Núm. 2, pp. 47-60
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
-
Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome
Journal of Clinical Medicine, Vol. 11, Núm. 6
-
Prognosis of Paradoxical Low-Flow Low-Gradient Aortic Stenosis: A Severe, Non-critical Form, With Surgical Treatment Benefits
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin
Molecular Oncology, Vol. 15, Núm. 12, pp. 3691-3705
-
Clinical characterization and outcomes of 85 patients with neurosarcoidosis
Scientific Reports, Vol. 11, Núm. 1
-
Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients
Joint Bone Spine, Vol. 88, Núm. 6
-
Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation
BMC Cardiovascular Disorders, Vol. 21, Núm. 1
-
Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
Frontiers in Immunology, Vol. 12
2020
-
Consensus document and recommendations on palliative care in heart failure of the Heart Failure and Geriatric Cardiology Working Groups of the Spanish Society of Cardiology
Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 69-77
-
FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes
Journal of the American Medical Directors Association, Vol. 21, Núm. 5, pp. 683-687.e1
-
Impact of Diabetes Mellitus and Frailty on Long-Term Outcomes in Elderly Patients with Acute Coronary Syndromes
Journal of Nutrition, Health and Aging, Vol. 24, Núm. 7, pp. 723-729
-
New Algorithms Improving PML Risk Stratification in MS Patients Treated With Natalizumab
Frontiers in Neurology, Vol. 11